Treatment of Spasticity in Patients with Brain Damage with the Association of Focused Shock Waves and Botulinum Toxin

Abstract  | Volume 2 | Issue 2 | JRS Jul – Dec 2022 | Page 26 | Antonio Déniz Cáceres, Pedro Saavedra Santana, María Isabel Marrero Arencibia, Jaime Hernández Alemán ,Almudena Hernández
DOI: 10.13107/jrs.2022.v02.i02.65

Author: Antonio Déniz Cáceres [1], Pedro Saavedra Santana [2], María Isabel Marrero  Arencibia [3], Jaime Hernández Alemán [4], Almudena Hernández [4]

[1] Rehabilitation Service, Hospital Universitario de Gran Canaria Dr. Negrín, Spain.

[2] Department of Mathematics, Universidad de Las Palmas de Gran Canaria, Spain.

[3] Department of Biochemestry and Molecular Biology, Universidad de Las Palmas de Gran Canaria, Spain.

[4] Universidad de Las Palmas de Gran Canaria, Spain.

Address of Correspondence
Dr. Antonio Déniz Cáceres, MD, PhD,
Rehabilitation Service, Hospital Universitario de Gran Canaria Dr. Negrín, Spain.
E-mail: antonio.deniz@ulpgc.es


Abstract

Introduction: Spasticity is a common complication in patients with brain damage secondary to stroke and multiple sclerosis, generating
disability and reducing the quality of life. In cases of muscles spasticity, we usually use Botulinum toxin injections (BTI) associated with
physiotherapy. Extracorporeal shock wave therapy (ESWT) is a safe, effective, and non-invasive treatment in these patients. Both methods are highly effective but currently are applied separately. Scientific evidence of the combined use of both techniques is scarce. The aim of this study is to assess the results of the association of both treatments (ESWT and BTI). On spasticity in patients secondary to stroke or multiple sclerosis.
Materials and Methods: This is a prospective study, with 6-month follow-up, including 10 adult patients with stroke or multiple sclerosis. ESWT was added to the usual treatment with BTI weekly for 3 weeks. The patients received rehabilitation during the treatment period and during the follow-up period. For statistical analysis in each of the follow-up weeks, the markers analyzed (spasticity and gait speed) were summarized in medians, which were plotted as a weekly function and the paired data were compared with the Wilcoxon test. The data were analyzed with an statistical program version 3.6.1 (R Development Core Team, 2019).
Results and Conclusions: We observed a statistically significant improvement in spasticity that was correlated with an increase in walking speed. The effectiveness of the combined treatment was superior and lasted longer than BTI alone.
Keywords: Shockwaves, Spasticity, Brain damage, Botulinum Toxin


 


How to Cite this article: Deniz A, Saavedra P, Marrero I, Hernández J, Hernández A | Treatment of Spasticity in Patients with Brain Damage with the Association of Focused Shock Waves and Botulinum Toxin. | Journal of Regenerative Science | Jul – Dec 2022; 2(2): 26.

[Full Text HTML] [Full Text PDF] [XML]


2022 Chinese Expert Consensus Statement on the Management of Extracorporeal Shockwave Therapy in Musculoskeletal Disorders during Novel Coronavirus Pandemic Prevention and Control

Review Article | Volume 2 | Issue 1 | JRS Jan – Jun 2022 | Page 27-31 | Fuqiang Gao , Xiangwei Ma , Wei Sun , Zirong Li , Jike Lu

DOI: 10.13107/jrs.2022.v02.i01.41

Author: Fuqiang Gao [1,2], Xiangwei Ma [3], Wei Sun [1,4], Zirong Li [1,2], Jike Lu [5]

[1] Shockwave Center, Department of Orthopedics, China-Japan Friendship Hospital, Chaoyang, Beijing, China.

[2] Beijing Key Laboratory of Immune Inflammatory Disease, China-Japan Friendship Hospital, Chaoyang, Beijing, China.

[3] Department of Rehabilitation Medicine, China-Japan Friendship Hospital, Chaoyang, Beijing, China.

[4] Department of Orthopaedic Surgery, School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

[5] Department of Orthopedics, Beijing United Family Hospital, Chaoyang, Beijing, China.

Address of Correspondence
Dr. Wei Sun, Shockwave Centers,
Department of Orthopedics, China-Japan Friendship Hospital, Chaoyang, Beijing, China.
E-mail: sun887@163.com


Abstract

Novel coronavirus pneumonia (corona virus disease 2019, [COVID-19]) is a novel respiratory infectious disease that has rapidly spread in many countries or regions around the world [1, 2, 3] . With the approval of the State Council, COVID-19 was included in the category B infectious diseases under the Law of the People’s People’s Republic of China on the Prevention and Control of Infectious Diseases, and the preventive and control measures for category A infectious diseases were adopted. Given the severity of the COVID-19 epidemic, the wide spread of transmission, and the human-to-human transmission, some patients with musculoskeletal disorders visiting hospitals and health care
workers engaged in medical shockwave technology are at potential risk of COVID-19 infection. The 2022 Chinese expert consensus statement on the Management of Musculoskeletal Disease Extracorporeal Shock Wave during the Prevention and Control of Novel Coronavirus Epidemic is formulated..

Keywords: Chinese expert consensus, Extracorporeal shockwave, Management, Musculoskeletal disorders, Novel coronavirus pandemic.


References:

1. Chang D, Lin M, Wei L, Xie L, Zhu G, Cruz CS, et al. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA2020;323:1092-3.
2. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: Adescriptive study. Lancet 2020;395:507-13.
3. Liu K, Fang YY, Deng Y, Liu W, Wang MF, Ma JP, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J Engl 2020;133:1025-31.
4. Riou J, Althaus CL. Pattern of early human-to-human transmission of Wuhan 2019 novel coronavirus (2019-nCoV), December 2019 to January 2020. Euro Surveill 2020;25:2000058.
5. Wölfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Müller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature 2020;581:465-9.
6. General Office of the National Health Commission, Office of the State Administration of Traditional Chinese Medicine. Pneumonia Diagnosis and Treatment Program for Novel Coronavirus Infection. 9th ed. New Delhi: General Office of the National Health Commission; 2022. Available from: http://www.gov.cn/zhengce/zhengceku/2022-03/15/content_5679257.htm last accessed on 2022.
7. Wei Y, Lu Y, Xia L, Yuan X, Li G, Li X, et al. Analysis of 2019 novel coronavirus infection and clinical characteristics of outpatients: An epidemiological study from a fever clinic in Wuhan, China. J Med Virol 2020;92:2758-67.
8. Krishnan A, Hamilton JP, Alqahtani SA, Woreta TA. A narrative review of coronavirus disease 2019 (COVID-19): Clinical, epidemiological characteristics, and systemic manifestations. Intern Emerg Med 2021;16:815-30.
9. Zhang J, Zhang B, Ni X. Questions about the implementation of management specifications for environmental surface cleaning and disinfection in medical institutions. Chin J Hosp Infect Dis 2018;28:473-6.
10. Fathizadeh H, Maroufi P, Momen-Heravi M, Dao S, Köse Ş, Ganbarov K, et al. Protection and disinfection policies against SARS-CoV-2 (COVID-19). Infez Med 2020;28:185-91.
11. Bielecki M, Patel D, Hinkelbein J, Komorowski M, Kester J, Ebrahim S, et al. Air travel and COVID-19 prevention in the pandemic and peri-pandemic period: A narrative review. Travel Med Infect Dis 2021;39:101915.
12. Wu W, Guan H, Fang Z, Guo F, You H, Xiao J, et al. Standardized process of orthopedic diagnosis and treatment during the outbreak of novel coronavirus pneumonia Recommendation. Orthopedics 2020;11:93-9.
13. Wilder-Smith A, Freedman DO. Isolation, quarantine, social distancing and community containment: Pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. J Travel Med 2020;27:taaa020.
14. Wong JS, Cheung KM. Impact of COVID-19 on orthopaedic and trauma service: An epidemiological study. J Bone Joint Surg Am 2020;102:e80.
15. Hirschmann MT, Hart A, Henckel J, Sadoghi P, Seil R, Mouton C. COVID-19 coronavirus: Recommended personal protective equipment for the orthopaedic and trauma surgeon. Knee Surg Sports Traumatol Arthrosc 2020;28:1690-8.

16. Wu S, Wang Y, Jin X, Tian J, Liu J, Mao Y. Environmental contamination by SARS-CoV-2 in a designated hospital for coronavirus disease 2019. Am J Infect Control 2020;48:910-4.
17. Tanaka MJ, Oh LS, Martin SD, Berkson EM. Telemedicine in the era of COVID-19: The virtual orthopaedic examination. J Bone Joint Surg Am 2020;102:e57.
18. Xie X, Zhong Z, Zhao W, Zheng C, Wang F, Liu J. Chest CT for typical coronavirus disease 2019 (COVID-19) pneumonia: Relationship to negative RT-PCR testing. Radiology 2020;296:E41-5.
19. Pan Y, Guan H, Zhou S, Wang Y, Li Q, Zhu T, et al. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV): Astudy of 63 patients in Wuhan, China. Eur Radiol 2020;30:3306-9.
20. Shockwave Medicine Professional Committee of China Research Hospital Association. Guidelines for extracorporeal shockwave therapy for musculoskeletal diseases in China. Chin J Med Front 2019;11:1-10.
21. Gao F, Sun W, Xing G. Interpretation of the latest diagnosis and treatment consensus of the International Society of Medical Shockwaves: Indications and contraindications of extracorporeal shockwave. Chin Med J 2017;97:2411-5.
22. Chinese Medical Association Physical Medicine and Rehabilitation Branch, Expert Consensus Group on Extracorporeal Shockwave Therapy for Musculoskeletal Diseases. Expert Consensus on Extracorporeal Shockwave Therapy for Musculoskeletal Diseases. Chin J Phys Med Rehabil 2019;41:481-7.

 


How to Cite this article: Gao F, Ma X, Sun W, Li Z, Lu J | 2022 Chinese Expert Consensus Statement on the Management of Extracorporeal Shockwave Therapy in Musculoskeletal Disorders during Novel Coronavirus Pandemic Prevention and Control. | Journal of Regenerative Science | Jan – Jun 2022; 2(1): 27-31.

[Full Text HTML] [Full Text PDF] [XML]


Shock Waves in Scaphoid Pseudarthrosis: A Case Series

Technical | Volume 2 | Issue 1 | JRS Jan – Jun 2022 | Page 39-42 | Paul German Terán1, Fidel Ernesto Cayon1, Estefania Anabel Lozada1, Alvaro Santiago Le Mari2

DOI: 10.13107/jrs.2022.v02.i01.47

Author: Paul German Terán [1], Fidel Ernesto Cayon [1], Estefania Anabel Lozada [1], Alvaro Santiago Le Marie [2]

[1] Department of Traumatology and Orthopedics, Orthopedic Specialties Center, Quito, Ecuador.

[2] Department of General and Laparoscopic Surgery, Universidad Internacional del Ecuador, Quito, Ecuador.

Address of Correspondence
Dr. Paul German Terán,
Department of Traumatology and Orthopedics, Orthopedic Specialties Center, Quito, Ecuador.
E-mail: paulteranmd@gmail.com


Abstract

Scaphoid fracture accounts for 60% of carpal fractures. The mechanism of fracture occurs after a fall with the hand extended, in pronation and radial or ulnar deviation in addition to the importance, they gain for their frequency; clinically, their problem lies in the high possibility of non-consolidation, due to the type of vascularization that it has, fractures located mainly in the waist and in the proximal pole are a high-risk factor. Most of the up-to-date papers available confirm a positive outcome of the use of focused extracorporeal shock wave therapy (ESWT-F) in pseudarthrosis. According to the literature, the success rate is between 50% and 91%. Complications when ESWT-F are performed by qualified personnel and following the standards established by international scientific organizations, are limited to petechiae and local hematomas having as a requirement, to be performed by trained personnel. This manuscript will discuss a series of cases treated in a certified center for the application of Focal Shock Waves between 2018 and 2021 to patients with scaphoid fracture with a diagnosis of Fracture Consolidation Delay and pseudarthrosis of scaphoids, which subjected to treatment with high-intensity focal shock waves under ultrasound guidance. We analyzed six male patients with an average age of 31.3 years who were treated with ESWT-F. About 33.3% were taken to osteosynthesis as initial management without achieving satisfactory bone consolidation; hence, ESWT-F was performed. About 0% complications were reported, bone consolidation occurred in 100% of patients on average of 6 weeks from the last session of ESWT-F. The results were clinically evaluated, where 100% of patients manifested a decrease in pain by an average of 75% at 2 weeks of the last session of ESWT-F and 100% at 12 weeks. In the imaging evaluation, the six patients (100%) showed signs of bone consolidation in the complete radiological assessment at 12 weeks and the Disabilities of the Arm, Shoulder, and Hand scale applied revealed improvement in their functional capacity.

Keywords: Scaphoid non-union, Delayed union, Extracorporeal shockwave therapy, Extracorporeal shock wave therapy, Pseudarthrosis, Disabilities of the arm, shoulder and hand


References:

1. Reigstad O, Thorkildsen R, Grimsgaard C, Melhuus K, Rokkum M. Examination and treatment of scaphoid fractures and pseudarthrosis. Tidsskr Nor Laegeforen 2015;135:1138-42.
2. Hernández PA, Arrieta DE, Lee Ruiz LS. Generalities of scaphoid fractures. Rev Med Sin 2020;5:e595.
3. Carreño F, Osma J. Orthopedics and Traumatology. Vol. 30. Amsterdam, Netherlands: Elsevier; 2016. p . 426-8. Available from: https://www.elsevier.es/es-revista-revista-colombiana-ortopedia-traumatologia-380-articulo-manguito-rotadores-epidemiologia-factores-riesgo-S0120884516300578. Last access on 2022.
4. Lee YM, Hwang ZO, Park JM, South YJ, Song SW. Double trapezia sign. Medicine (Baltimore) 2020;99:e22460.
5. Garcia AG. Fractures of the carpal scaphoid. Cir Cir 1953;21:199-206.
6. Valchanou VD, Michailov P. High energy shock waves in the treatment of delayed and nonunion of fractures. Int Orthop 1991;15:181-4.
7. Schleusser S, Song J, Stang FH, Mailaender P, Kraemer R, Kisch T. Blood flow in the scaphoid is improved by focused extracorporeal shock wave therapy. Clin Orthop Relat Res 2020;478:127-35.
8. Figures VJ, Azócar SC, Sanhueza FM, Cavalla AP, Liendo VR. Arthroscopic management of scaphoid pseudoarthrosis with hump deformity: Surgical technique and case series. Rev Chil Ortop Traumatol 2019;60:47-57.
9. Vázquez JM, Galindo JC. Delay of consolidation and pseudoarthrosis of the scaphoid. Medigr Artemis 2007;3:259-68.
10. Vergara EM. Vascularized bone graft for the scaphoid. Investig Orig 2011;59:281.
11. Knobloch K. Extracorporeal magnetotransduction therapy (EMTT) and high-energetic focused extracorporeal shockwave therapy (ESWT) as bone stimulation therapy for metacarpal non-union a case report. Handchir Mikrochir Plast Chir 2021;53:82-6.

12. Fallnhauser T, Wilhelm P, Priol A, Windhofer C. High-energy extracorporeal shock wave therapy in delayed healing of scaphoid fractures and non-unions: Aretrospective analysis of the consolidation rate and factors relevant to therapy decisions. Handchir Microchir Plast Chir 2019;51:164-70.
13. Terán Vela P, Abarca WI, Martínez Asnalema D. Extracorporeal shock waves as a non-surgical treatment of delay of consolidation and non-bone union in diaphyseal fracture of the humerus associated with axonotmesis of the radial nerve, clinical case and literature review. Rev Ecu Med EUGENIO ESPEJO 2019;5:52-66.
14. Moya D, Ramón S, Guiloff L, Terán P, Eid J, Serrano E. Poor results and complications in the use of focal shock waves and radial pressure waves in musculoskeletal pathology. Rehabilitation 2021;4:13-18.
15. D’Agostino MC, Craig K, Tibalt E, Respizzi S. Shock wave as biological therapeutic tool: From mechanical stimulation to recovery and healing, through mechanotransduction. Int J Surg 2015;24:147-53.
16. Wang CJ, Cheng JH, Huang CC, Yip HK, Russo S. Extracorporeal shockwave therapy for avascular necrosis of femoral head. Int J Surg 2015;24:184-7.
17. Cheng JH, Wang CJ. Biological mechanism of shockwave in bone. Int J Surg 2015;24:143-6.
18. Wang CJ. Extracorporeal shockwave therapy in musculoskeletal disorders. J Orthop Surg Res 2012;7:11.
19. Balius R, Jimenez F. Interventional Ultrasound in Sports Traumatology. I. Madrid; 2015. p. 2-4.

 


How to Cite this article: Teran PG, Cayon FE, Lozada EA, Le Marie AS | Shock Waves in Scaphoid Pseudarthrosis: A Case Series. | Journal of Regenerative Science | Jan – Jun 2022; 2(1): 39-42.

[Full Text HTML] [Full Text PDF] [XML]


Treatment of a Femoral Shaft Non-union in a Pediatric Patient with Focused Shock Waves

Case Report | Volume 2 | Issue 1 | JRS Jan – Jun 2022 | Page 36-38 | Sebastián Senes1, Gerardo Staudacher2,  Santiago Iglesias1, Daniel Moya1, Rodolfo Goyeneche2

DOI: 10.13107/jrs.2022.v02.i01.45

Author: Sebastián Senes [1], Gerardo Staudacher [2],  Santiago Iglesias [1], Daniel Moya[1], Rodolfo Goyeneche [2]

[1] Servicio de Ortopedia y Traumatología, Hospital Británico de Buenos Aires, Argentina.

[2] Servicio de Ortopedia y Traumatología Infantil, Hospital de Pediatría Garrahan, Buenos Aires, Argentina.

Address of Correspondence
Dr. Daniel Moya, MD,
Hospital Británico de Buenos Aires, Perdriel 74, C1280 AEB, CABA, Argentina.
E-mail: drdanielmoya@yahoo.com.ar


Abstract

Non-unions of the femur in children are not frequent, but when they do occur they can be very difficult to manage. Shock wave therapy has emerged as an effective option for well-chosen pseudoarthrosis cases, however there are no reports of pediatric cases. We report a 12-year-old male patient with a history of pathological fracture due to mid-diaphyseal osteomyelitis of the right femur at 8 years of age. After several surgical procedures the integrity of the femur was restored but an area of non-unions persisted at mid-diaphyseal level. He was treated with 3 sessions of focused shock waves with an electrohydraulic generator. He presented a rapid consolidation, avoiding a new endomedullary nailing surgery with bone graft.

Focused shock waves may be a useful therapeutic option in children with nonunions in well-selected cases.

Keywords: Pediatric, Fracture non-unions, Shock Waves


References:

1. Lewallen RP, Peterson HA. Nonunion of long bone fractures in children: a review of 30 cases. J Pediatr Orthop. 1985 Mar-Apr;5(2):135-42. PMID: 3988913.

2. Rockwood, Charles A., Kaye E. Wilkins, James H. Beaty, and James R. Kasser. Rockwood and Wilkins’ Fractures in Children. Philadelphia: Lippincott Williams & Wilkins, 2001

3. Valchanou VD, Michailov P. High energy shock waves in the treatment of delayed and nonunion of fractures. Int Orthop. 1991;15(3):181-4. doi: 10.1007/BF00192289. PMID: 1743828.
4. Moya D, Ramón S, Schaden W, Wang CJ, Guiloff L, Cheng JH. The Role of Extracorporeal Shockwave Treatment in Musculoskeletal Disorders. J Bone Joint Surg Am. 2018 Feb 7;100(3):251-263. doi: 10.2106/JBJS.17.00661. PMID: 29406349.
5. Haupt G, Haupt A, Ekkernkamp A, Gerety B, Chvapil M. Influence of shock waves on fracture healing. Urology. 1992 Jun;39(6):529-32. doi: 10.1016/0090-4295(92)90009-l. PMID: 1615601.
6. Haupt G. Use of extracorporeal shock waves in the treatment of pseudarthrosis, tendinopathy and other orthopedic diseases. J Urol. 1997 Jul;158(1):4-11. doi: 10.1097/00005392-199707000-00003. PMID: 9186313.
7. Rompe JD, Rosendahl T, Schöllner C, Theis C. High-energy extracorporeal shock wave treatment of nonunions. Clin Orthop Relat Res. 2001 Jun;(387):102-11. doi: 10.1097/00003086-200106000-00014. PMID: 11400870.
8. Wang CJ, Chen HS, Chen CE, Yang KD. Treatment of nonunions of long bone fractures with shock waves. Clin Orthop Relat Res. 2001 Jun;(387):95-101. doi: 10.1097/00003086-200106000-00013. PMID: 11400901.
9. Schaden W, Fischer A, Sailler A. Extracorporeal shock wave therapy of nonunion or delayed osseous union. Clin Orthop Relat Res. 2001 Jun;(387):90-4. doi: 10.1097/00003086-200106000-00012. PMID: 11400900.
10. Elster EA, Stojadinovic A, Forsberg J, Shawen S, Andersen RC, Schaden W. Extracorporeal shock wave therapy for nonunion of the tibia. JOrthop Trauma. 2010 Mar; 24(3):133-41.doi: 10.1097/BOT.0b013e3181b26470. PMID: 20182248.
11. Kuo SJ, Su IC, Wang CJ, Ko JY. Extracorporeal shockwave therapy (ESWT) in the treatment of atrophic non-unions of femoral shaft fractures. Int J Surg. 2015 Dec;24(Pt B):131-4. doi: 10.1016/j.ijsu.2015.06.075. Epub 2015 Jul 9. PMID: 26166737.
12. Cacchio A, Giordano L, Colafarina O, Rompe JD, Tavernese E, Ioppolo F, Flamini S, Spacca G, Santilli V. Extracorporeal shock-wave therapy compared with surgery for hypertrophic long-bone nonunions. J Bone Joint Surg Am. 2009 Nov;91(11):2589-97. doi: 10.2106/JBJS.H.00841. Erratum in: J Bone Joint Surg Am. 2010 May;92(5):1241. PMID: 19884432.
13. Notarnicola A, Moretti L, Tafuri S, Gigliotti S, Russo S, Musci L, Moretti B. Extracorporeal shockwaves versus surgery in the treatment of pseudoarthrosis of the carpal scaphoid. Ultrasound Med Biol. 2010 Aug;36(8):1306-13. doi: 10.1016/j.ultrasmedbio.2010.05.004. PMID: 20691920.
14. Furia JP, Juliano PJ, Wade AM, Schaden W, Mittermayr R. Shock wave therapy compared with intramedullary screw fixation for nonunion of proximal fifth metatarsal metaphyseal-diaphyseal fractures. J Bone Joint Surg Am. 2010 Apr;92(4):846-54. doi: 10.2106/JBJS.I.00653. PMID: 20360507.
15. W. Schaden, M. Pusch, C. Schwab, R. Mittermayr, H. Kuderna. Grundlagen der extrakorporalen Stoßwellentherapie (ESWT) bei Pseudarthrosen. Quality for the treated and practitioners. 47th Annual Meeting, Salzburg, Austria, 2011.
16. International Society for Medical Shockwave Treatment. Indications. https://www.shockwavetherapy.org/about-eswt/indications/ Last Access, June 15th,2022.

 


How to Cite this article: Senes S, Staudacher G, Iglesias S, Moya D, Goyeneche R | Treatment of a femoral shaft non-union in a pediatric patient with focused shock waves | Journal of Regenerative Science | Jan – Jun 2022; 2(1): 36-38.

[Full Text HTML] [Full Text PDF] [XML]


Novel Extracorporeal Magnetotransduction Therapy with Magnetolith® and Focused Electromagnetic Extracorporeal Shockwave Therapy in Medial Meniscal Tear – A Case Report

Case Report | Volume 2 | Issue 1 | JRS Jan – Jun 2022 | Page 32-35 | Karsten Knobloch

DOI: 10.13107/jrs.2022.v02.i01.43

Author: Karsten Knobloch [1]

[1] Sport Praxis Prof. Knobloch, Hannover, Germany.

Address of Correspondence
Prof. Dr. Karsten Knobloch,
Heiligerstr. 3, Hannover – 30159, Germany.
E-mail: professor.knobloch@sportpraxis-knobloch.de


Abstract

The case report describes a non-invasive combination of novel extracorporeal magnetotransduction therapy (EMTT) with focused extracorporeal shockwave therapy for symptomatic medial meniscal tear in a 41-year-old gentleman. Ultra-high-frequency 33 MHz ultrasound revealed a complex medial meniscal tear with a ganglion confirmed by subsequent magnetic resonance imaging. Non-invasive treatment with combined novel Magnetolith® EMTT with focused electromagnetic extracorporeal shockwave therapy for three sessions on a weekly interval. Shear wave elastography at 6 months demonstrated comparable stiffness of the healed and the healthy contralateral meniscus. The healing of the meniscal tear could be depicted by multiparametric ultra-high-frequency ultrasound (33 MHz) with novel stress testing and shear wave elastography.

Keywords: Magnetic field, Extracorporeal shockwave therapy, Extracorporeal shockwave therapy, Meniscal, Ultrasound, Pain


References:

1. Avendaño-Coy J, Comino-Suárez N, Grande-Muñoz J, Avendaño-López C, Gómez-Soriano J. Extracorporeal shockwave therapy improves pain and function in subjects with knee osteoarthritis: A systematic review and meta-analysis of randomized clinical trials. Int J Surg 2020;82:64-75.
2. Bedewi MA, Elsifey AA, Saleh AK, Alfaifi T. Shear wave elastography of the knee menisci. J Int Med Res 2020;48:300060520976048.
3. Beutler S, Regel G, Pape HC, Machtens S, Weinberg AM, Kremeike I, et al. Extracorporeal shock wave therapy for delayed union of long bone fractures – Preliminary results of a prospective cohort study. Unfallchirurg 1999;102:839-47.
4. Lu CC, Chou SH, Shen PC, Chou PH, Ho ML, Tien YC. Extracorporeal shock wave promotes activation of anterior cruciate ligament remnant cells and their paracrine regulation of bone marrow stromal cells’ proliferation, migration, collagen synthesis, and differentiation. Bone Joint Res 2020;9:458-68..
5. d’Agostino MC, Craig K, Tibalt E, Respizzi S. Shock wave as biological therapeutic tool: From mechanical stimulation to recovery and healing, through mechanotransduction. Int J Surg 2015;24:147-53.
6. Gollmann-Tepeköylü C, Pölzl L, Graber M, Hirsch J, Nägele F, Lobenwein D, et al. miR-19a-3p containing exosomes improve function of ischaemic myocardium upon shock wave therapy. Cardiovasc Res 2020;116:1226-36.
7. Hashimoto S, Ichinose T, Ohsawa T, Koibuchi N, Chikuda H. Extracorporeal shockwave therapy accelerates the healing of a meniscal tear in the avascular region in a rat model. Am J Sports Med 2019;47:2937-44.
8. Hsu CC, Cheng JH, Wang CJ, Ko JY, Hsu SL, Hsu TC. Shockwave therapy combined with autologous adipose-derived mesenchymal stem cells is better than with human umbilical cord Wharton’s Jelly-derived mesenchymal stem cells on knee osteoarthritis. Int J Mol Sci 2020;21:1217.
9. Knobloch K. Novel extracorporeal magnetotransduction therapy with Magnetolith and high-energy focused electromagnetic extracorporeal shockwave therapy as bone stimulation therapy for scaphoid nonunion – A case report. Med Case Rep Study Protoc 2020;2:1.
10. Knobloch K. Extracorporeal magnetotransduction therapy (EMTT) and high-energetic focused extracorporeal shockwave therapy (ESWT) as bone stimulation therapy for metacarpal non-union – A case report. Handchir Mikrochir Plast Chir 2021;53:82-6.
11. Knobloch K. Bone stimulation 4.0 – Combination of EMTT & EMTT in humerus nonunion. Unfallchirurg 2022;125:323-6.
12. Klüter T, Krath A, Stukenberg M, Gollwitzer H, Harrasser N, Knobloch K, et al. Electromagnetic transduction therapy and shockwave therapy in 86 patients with rotator cuff tendinopathy: A prospective randomized controlled trial. Electromagn Biol Med 2018;37:175-83.
13. Kopf S, Beaufils P, Hirschmann MT, Rotigliano N, Ollivier M, Pereira H, et al. Management of traumatic meniscus tears: The 2019 ESSKA meniscus consensus. Knee Surg Sports Traumatol Arthrosc 2020;28:1177-94.
14. Krath A, Klüter T, Stukenberg M, Zielhardt P, Gollwitzer H, Harrasser N, et al. Electromagnetic transduction therapy in non-specific low back pain: A prospective randomised controlled trial. J Orthop 2017;14:410-5.
15. Lohmander LS, Englund PM, Dahl LL, Roos EM. The long-term consequence of anterior cruciate ligament and meniscus injuries: Osteoarthritis. Am J Sports Med 2007;35:1756-69.
16. Moretti B, Notarnicola A, Garofalo R, Moretti L, Patella S, Marlinghaus E, et al. Shock waves in the treatment of stress fractures. Ultrasound Med Biol 2009;35:1042-9.
17. Ouyang J, Zhang B, Kuang L, Yang P, Du X, Qi H, et al. Pulsed electromagnetic field inhibits synovitis via enhancing the efferocytosis of macrophages. Biomed Res Int 2020;2020:4307385.
18. Pölzl L, Nägele F, Hirsch J, Graber M, Grimm M, Gollmann-Tepeköylü C, et al. Exosome isolation after in vitro shock wave therapy. J Vis Exp 2020;(163). doi: 10.3791/61508.
19. Riley DS, Barber MS, Kienle GS, Aronson JK, von Schoen-Angerer T, Tugwell P, et al. CARE guidelines for case reports: Explanation and elaboration document. J Clin Epidemiol 2017;89:218-35.
20. Schaden W, Mittermayr R, Haffner N, Smolen D, Gerdesmeyer L, Wang CJ. Extracorporeal shockwave therapy (ESWT) – First choice treatment of fracture non-unions? Int J Surg 2015;24:179-83.
21. Kim SH, Lee HJ, Jang YH, Chun KJ, Park YB. Diagnostic accuracy of magnetic resonance imaging in the detection of type and location of meniscus tears: Comparison with arthroscopic findings. J Clin Med 2021;10:606.
22. Tang X, Coughlin D, Ballatori A, Berg-Johansen B, Waldorff EI, Zhang N, et al. Pulsed electromagnetic fields reduce interleukin-6 expression in intervertebral disc cells via nuclear factor-κβ and mitogen-activated protein kinase p38 pathways. Spine (Phila Pa 1976) 2019;44:E1290-7.
23. Wesdorp MA, Eijgenraam SM, Meuffels DE, Bierma-Zeinstra SM, Kleinrensink GJ, Bastiaansen-Jenniskens YM, et al. Traumatic meniscal tears are associated with meniscal degeneration. Am J Sports Med 2020;48:2345-52.
24. Willems A, van der Jagt OP, Meuffels DE. Extracorporeal shock wave treatment for delayed union and nonunion fractures: Asystematic review. J Orthop Trauma 2019;33:97-103.
25. Zhao Z, Wang Y, Wang Q, Liang J, Hu W, Zhao S, et al. Radial extracorporeal shockwave promotes subchondral bone stem/progenitor cell self-renewal by activating YAP/TAZ and facilitates cartilage repair in vivo. Stem Cell Res Ther 2021;12:19.

 


How to Cite this article: Knobloch K | Novel Extracorporeal Magnetotransduction Therapy with Magnetolith® and Focused Electromagnetic Extracorporeal Shockwave Therapy in Medial Meniscal Tear – A Case Report | Journal of Regenerative Science | Jan – Jun 2022; 2(1): 32-35.

[Full Text HTML] [Full Text PDF] [XML]


Extracorporeal Shockwave Treatment for Managing Biofilm-mediated Infections in Dentistry: Current Knowledge and Future Perspectives

Review Article | Volume 2 | Issue 1 | JRS Jan – Jun 2022 | Page 22-26 | Antonia Olivares, Christina M A P Schuh, Sebastian Aguayo

DOI: 10.13107/jrs.2022.v02.i01.39

Author: Antonia Olivares [1], Christina M A P Schuh [2], Sebastian Aguayo [1,3]

[1] School of Dentistry, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.

[2] Centro de Medicina Regenerativa, Facultad de Medicina, Clínica Alemana-Universidad del Desarrollo, Santiago, Chile.

[3] Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.

Address of Correspondence
Dr. Sebastian Aguayo,
School of Dentistry and Institute for Biological and Medical Engineering, Schools of Engineering, Medicine and Biological Sciences, Pontificia Universidad Católica de Chile, Santiago, Chile.
E-mail: sebastian.aguayo@uc.cl


Abstract

At present, chronic non-communicable diseases are becoming more prevalent across the world. Among these pathologies, oral diseases such as dental caries and periodontitis are some of the most frequently observed in populations worldwide. These biofilm-mediated infections are produced as a consequence of a series of factors that modify the oral microenvironment and lead to dysbiosis among residing biofilms, which are particularly difficult to treat with pharmacological approaches due to their structural and anatomical characteristics. Furthermore, the recent sharp increase in antimicrobial resistance has potentiated the need for the development of novel techniques to effectively treat biofilm-mediated diseases in the mouth. One option that has recently shown promising results in vitro is the use of focused high-energy extracorporeal shockwave therapy (fhESWT) for the control of microbial growth and biofilm formation. Several studies have shown the effect of fhESWT on the treatment of biofilm-mediated infections associated with bone fractures and orthopedic implant infection, although the mechanisms behind this effect are still unknown. Regarding the oral cavity, there remains a lack of clinical studies but there are some limited in vitro and in vivo investigations that shed light on the potential of fhESWT for biofilm control. Therefore, the objective of this review is to discuss the most relevant available literature regarding the in vitro and in vivo effects of fhESWT over biofilm control, as well as the potential use of fhESWT for the treatment of oral biofilm-mediated diseases in the future.

Keywords: Bacteria, Biofilms, Extracorporeal shockwave therapy, Focused high-energy extracorporeal shockwave therapy, Fungi, Microorganisms.


References:

1. Deo PN, Deshmukh R. Oral microbiome: Unveiling the fundamentals. J Oral Maxillofac Pathol 2019;23:122-8.
2. Römling U, Kjelleberg S, Normark S, Nyman L, Uhlin BE, Åkerlund B. Microbial biofilm formation: Aneed to act. J Intern Med 2014;276:98-110.
3. Zijnge V, van Leeuwen MB, Degener JE, Abbas F, Thurnheer T, Gmür R, et al. Oral biofilm architecture on natural teeth. PLoS One 2010;5:e9321.
4. Hojo K, Nagaoka S, Ohshima T, Maeda N. Bacterial interactions in dental biofilm development. J Dent Res 2009;88:982-90.
5. Aguayo S, Donos N, Spratt D, Bozec L. Nanoadhesion of Staphylococcus aureus onto titanium implant surfaces. J Dent Res 2015;94:1078-84.
6. Schmidlin PR, Müller P, Attin T, Wieland M, Hofer D, Guggenheim B. Polyspecies biofilm formation on implant surfaces with different surface characteristics. J Appl Oral Sc 2013;21:48-55.
7. Simon-Soro A, Ren Z, Krom BP, Hoogenkamp MA, Cabello-Yeves PJ, Daniel SG, et al. Polymicrobial aggregates in human saliva build the oralbiofilm. mBio 2022;13:e0013122.
8. Aguayo S, Bozec L. Mechanics of bacterial cells and initial surface colonisation. In: Leake MC, editor. Biophysics of Infection. Cham: Springer. International Publishing; 2016. p. 245-60.
9. Avilés-Reyes A, Miller JH, Lemos JA, Abranches J. Collagen-binding proteins of Streptococcus mutans and related streptococci. Mol Oral Microbiol 2017;32:89-106.
10. Álvarez S, Leiva-Sabadini C, Schuh CM, Aguayo S. Bacterial adhesion to collagens: Implications for biofilm formation and disease progression in the oral cavity. Crit Rev Microbiol 2021;48:1-13.
11. Rabin N, Zheng Y, Opoku-Temeng C, Du Y, Bonsu E, Sintim HO. Biofilm formation mechanisms and targets for developing antibiofilm agents. Future Med Chem 2015;7:493-512.
12. Souza JG, Costa RC, Sampaio AA, Abdo VL, Nagay BE, Castro N, et al. Cross-kingdom microbial interactions in dental implant-related infections: Is Candida albicans a new villain? iScience 2022;25:103994.
13. Wan SX, Tian J, Liu Y, Dhall A, Koo H, Hwang G. Cross-kingdom cell-to-cell interactions in cariogenic biofilm initiation. J Dent Res 2021;100:74-81.
14. Digel I, Kern I, Geenen EM, Akimbekov N. Dental plaque removal by ultrasonic toothbrushes. Dent J (Basel) 2020;8:28.
15. Abisado RG, Benomar S, Klaus JR, Dandekar AA, Chandler JR. Bacterial quorum sensing and microbial community interactions. mBio 2018;9:e02331-17.
16. Pitts NB, Zero DT, Marsh PD, Ekstrand K, Weintraub JA, Ramos-Gomez F, et al. Dental caries. Nat Rev Dis Prim 2017;3:17030.
17. Singhrao SK, Harding A, Poole S, Kesavalu L, Crean SJ. Porphyromonas gingivalis periodontal infection and its putative links with Alzheimer’s disease. Mediators Inflamm 2015;2015:137357.
18. Sousa V, Nibali L, Spratt D, Dopico J, Mardas N, Petrie A, et al. Peri-implant and periodontal microbiome diversity in aggressive periodontitis patients: Apilot study. Clin Oral Implants Res 2017;28:558-70.
19. Hajishengallis G, Darveau RP, Curtis MA. The keystone-pathogen hypothesis. Nat Rev Microbiol 2012;10:717-25.
20. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: A systematic analysis for the global burden of disease study 2017. Lancet 2018;392:1789-858.
21. Jin LJ, Lamster IB, Greenspan JS, Pitts NB, Scully C, Warnakulasuriya S. Global burden of oral diseases: Emerging concepts, management and interplay with systemic health. Oral Dis 2016;22:609-19.
22. Kazeminia M, Abdi A, Shohaimi S, Jalali R, Vaisi-Raygani A, Salari N, et al. Dental caries in primary and permanent teeth in children’s worldwide, 1995 to 2019: A systematic review and meta-analysis. Head Face Med 2020;16:22.
23. Petersen PE, Ogawa H. The global burden of periodontal disease: Towards integration with chronic disease prevention and control. Periodontol 2000 2012;60:15-39.
24. Xu W, Zhou W, Wang H, Liang S. Roles of Porphyromonas gingivalis and its virulence factors in periodontitis. Adv Protein Chem Struct Biol 2020;120:45-84.
25. Smeets R, Henningsen A, Jung O, Heiland M, Hammächer C, Stein JM. Definition, etiology, prevention and treatment of peri-implantitis a review. Head Face Med 2014;10:34.
26. Millsop JW, Fazel N. Oral candidiasis. Clin Dermatol 2016;34:487-94.

27. Aguayo S, Marshall H, Pratten J, Bradshaw D, Brown JS, Porter SR, et al. Early adhesion of Candida albicans onto dental acrylic surfaces. J Dent Res 2017;96:917-23.
28. Grigalauskienė R, Slabšinskienė E, Vasiliauskienė I. Biological approach of dental caries management. Stomatologija 2015;17:107-12.
29. Jirau-Colón H, González-Parrilla L, Martinez-Jiménez J, Adam W, Jiménez-Velez B. Rethinking the dental amalgam dilemma: An integrated toxicological approach. Int J Environ Res Public Health 2019;16:1036.
30. Fischer RG, Lira R Jr., Retamal-Valdes B, de Figueiredo LC, Malheiros Z, Stewart B, et al. Periodontal disease and its impact on general health in Latin America. Section V: Treatment of periodontitis. Braz Oral Res 2020;34:e026.
31. Bescos R, Ashworth A, Cutler C, Brookes ZL, Belfield L, Rodiles A, et al. Effects of chlorhexidine mouthwash on the oral microbiome. Sci Rep 2020;10:5254.
32. Kuang X, Chen V, Xu X. Novel approaches to the control of oral microbial biofilms. Biomed Res Int 2018;2018:6498932.
33. Leiva-Sabadini, C, Alvarez, S, Barrera NP, Schuh CM, Aguayo S. Antibacterial effect of honey-derived exosomes containing antimicrobial peptides against oral streptococci. Int J Nanomed 2021;16:4891-900.
34. Ogden JA, Tóth-Kischkat A, Schultheiss R. Principles of shock wave therapy. Clin Orthop Relat Res 2001;387:8-17.
35. Mirea A, Onose G, Padure L, Rosulescu E. Extracorporeal shockwave therapy (ESWT) benefits in spastic children with cerebral palsy (CP). J Med Life 2014;7:127-32.
36. Chaussy CG. The history of shockwave lithotripsy. In: Patel SR, Moran ME, Nakada SY, editors. The History of Technologic Advancements in Urology. Cham: Springer International Publishing; 2018. p. 109-21.
37. Elster EA, Stojadinovic A, Forsberg J, Shawen S, Andersen RC, Schaden W. Extracorporeal shock wave therapy for nonunion of the tibia. J Orthop Trauma 2010;24:133-41.
38. Schaden W, Fischer A, Sailler A. Extracorporeal shock wave therapy of nonunion or delayed osseous union. Clin Orthop Relat Res 2001;387:90-4.
39. Mittermayr R, Hartinger J, Antonic V, Meinl A, Pfeifer S, Stojadinovic A, et al. Extracorporeal shock wave therapy (ESWT) minimizes ischemic tissue necrosis irrespective of application time and promotes tissue revascularization by stimulating angiogenesis. Ann Surg 2011;253:1024-32.
40. Wang CJ, Cheng JH, Kuo YR, Schaden W, Mittermayr R. Extracorporeal shockwave therapy in diabetic foot ulcers. Int J Surg 2015;24:207-9.
41. Puetzler J, Milstrey A, Everding J, Raschke M, Arens D, Zeiter S, et al. Focused high-energy extracorporeal shockwaves as supplemental treatment in a rabbit model of fracture-related infection. J Orthop Res 2020;38:1351-8.
42. Qi X, Zhao Y, Zhang J, Han D, Chen C, Huang Y, et al. Increased effects of extracorporeal shock waves combined with gentamicin against Staphylococcus aureus biofilms in vitro and in vivo. Ultrasound Med Biol 2016;42:2245-52.
43. Milstrey A, Rosslenbroich S, Everding J, Raschke MJ, Richards RG, Moriarty TF, et al. Antibiofilm efficacy of focused high-energy extracorporeal shockwaves and antibiotics in vitro. Bone Joint Res 2021;10:77-84.
44. Datey A, Thaha CS, Patil SR, Gopalan J, Chakravortty D. Shockwave therapy efficiently cures multispecies chronic periodontitis in a humanized rat model. Front Bioeng Biotechnol 2019;7:382.

 


How to Cite this article: Olivares A, Schuh CMAP, Aguayo S | Extracorporeal Shockwave Treatment for Managing Biofilm-mediated Infections in Dentistry: The Current Knowledge and Future Perspectives | Journal of Regenerative Science | Jan – Jun 2022; 2(1): 22-26.

[Full Text HTML] [Full Text PDF] [XML]